218 related articles for article (PubMed ID: 24106398)
21. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
[TBL] [Abstract][Full Text] [Related]
22. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
[TBL] [Abstract][Full Text] [Related]
23. Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats.
Huang WC; Lin JY; Wallace CG; Chuang WY; Wei FC; Liao SK
Plast Reconstr Surg; 2010 Apr; 125(4):1095-1103. PubMed ID: 20072086
[TBL] [Abstract][Full Text] [Related]
24. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens.
Shirasugi N; Adams AB; Durham MM; Lukacher AE; Xu H; Rees P; Cowan SR; Williams MA; Pearson TC; Larsen CP
J Immunol; 2002 Sep; 169(5):2677-84. PubMed ID: 12193741
[TBL] [Abstract][Full Text] [Related]
25. Intra-bone Bone Marrow Transplantation in Pig-to-Nonhuman Primates for the Induction of Tolerance Across Xenogeneic Barriers.
Yamada K; Ariyoshi Y; Pomposelli T; Takeuchi K
Methods Mol Biol; 2020; 2110():213-225. PubMed ID: 32002911
[TBL] [Abstract][Full Text] [Related]
26. Recent progress in tolerance induction through mixed chimerism.
Pree I; Pilat N; Wekerle T
Int Arch Allergy Immunol; 2007; 144(3):254-66. PubMed ID: 17596699
[TBL] [Abstract][Full Text] [Related]
27. Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.
Yamada Y; Ochiai T; Boskovic S; Nadazdin O; Oura T; Schoenfeld D; Cappetta K; Smith RN; Colvin RB; Madsen JC; Sachs DH; Benichou G; Cosimi AB; Kawai T
Am J Transplant; 2014 Dec; 14(12):2704-12. PubMed ID: 25394378
[TBL] [Abstract][Full Text] [Related]
28. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
Chen B; Xu H; Corbin DR; Ildstad ST
Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
[TBL] [Abstract][Full Text] [Related]
29. Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning.
Seung E; Mordes JP; Rossini AA; Greiner DL
J Clin Invest; 2003 Sep; 112(5):795-808. PubMed ID: 12952928
[TBL] [Abstract][Full Text] [Related]
30. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
31. Mixed chimerism and split tolerance: mechanisms and clinical correlations.
Al-Adra DP; Anderson CC
Chimerism; 2011; 2(4):89-101. PubMed ID: 22509425
[TBL] [Abstract][Full Text] [Related]
32. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
33. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
34. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance.
Chen JC; Kuo ML; Ou LS; Chang PY; Muench MO; Shen CR; Chang HL; Yu HY; Fu RH
Cell Transplant; 2010; 19(12):1609-22. PubMed ID: 20719075
[TBL] [Abstract][Full Text] [Related]
35. Establishing immunological tolerance through the induction of molecular chimerism.
Bagley J; Bracy JL; Tian C; Kang ES; Iacomini J
Front Biosci; 2002 May; 7():d1331-7. PubMed ID: 11991829
[TBL] [Abstract][Full Text] [Related]
36. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
[TBL] [Abstract][Full Text] [Related]
37. Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts.
Huang WC; Lin JY; Wallace CG; Wei FC; Liao SK
Clin Dev Immunol; 2012; 2012():107901. PubMed ID: 23118778
[TBL] [Abstract][Full Text] [Related]
38. Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.
Xu H; Zhu Z; Huang Y; Bozulic LD; Hussain LR; Yan J; Ildstad ST
Transplantation; 2012 Mar; 93(5):469-76. PubMed ID: 22228418
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
